Testing effectiveness (Phase 2)Study completedNCT00537524
What this trial is testing
Immunogenicity, Safety and Tolerability of Two Doses of a Pre-pandemic Influenza Vaccine in Participants Aged 6 Months to 17 Years
Who this might be right for
Prophylaxis of Avian Influenza
Novartis Vaccines 471